Dagmar Pich
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Assessing the fitness of Epstein-Barr virus following its reactivation.
Journal: Journal of virology
Published: May 30, 2025
SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests.
Journal: Biomedicines
Published: October 04, 2023
Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model.
Journal: Vaccines
Published: December 14, 2022
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test.
Journal: PNAS nexus
Published: November 16, 2022
Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation.
Journal: Nucleic acids research
Published: January 06, 2021
Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection.
Journal: PLoS pathogens
Published: November 19, 2020
Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL.
Journal: Biomarker research
Published: August 20, 2020
First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
Journal: mBio
Published: September 19, 2019
Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 26, 2019
Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 18, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026